Get the latest tech news
Metyos is building a biowearable to monitor chronic kidney disease
Alexandre Boulanger is better know for building self-balancing exoskeletons at Wandercraft. For his next trick the Paris-based robotics entrepreneur is Alexandre Boulanger is better know for building self-balancing exoskeletons at Wandercraft. For his next trick the Paris-based robotics entrepreneur is fronting work on a far lighter kind of wearable...
The medtech startup — Metyos — where Boulanger is CEO, is a joint effort: Co-founded with CTO Olga Chashchina, who holds a PhD in biomedical engineering where she gained particular expertise with biosensors that’s critical to what the pair are cooking up here. Metyos’ goal is to build similar arm-worn (semi-invasive) real-time sensing tech as is already established for diabetes management, so which can also detect chemical changes in fluids just under the skin, but which is focused on tracking biomarkers linked to chronic kidney condition. Boulanger lists five startups as its main competitors: Biolinq, Alio, Protonintel, Kalium Health and Renalyse — the latter two also focus on kidney conditions but in their case patient tracking is based on at-home blood draws, rather than real-time data being pulled from a biowearable.
Or read this on TechCrunch